Becton Dickinson EBITDA 2010-2024 | BDX

Becton Dickinson EBITDA for the quarter ending September 30, 2024 was $1.170B, a 4.65% increase year-over-year.

  • Becton Dickinson 2023 EBITDA was 4.399B, a 2.5% decline from 2022.
  • Becton Dickinson 2022 EBITDA was 4.512B, a 0.69% increase from 2021.
  • Becton Dickinson 2021 EBITDA was 4.481B, a 48.03% increase from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Becton Dickinson EBITDA 2010-2024 | BDX

  • Becton Dickinson 2023 EBITDA was 4.399B, a 2.5% decline from 2022.
  • Becton Dickinson 2022 EBITDA was 4.512B, a 0.69% increase from 2021.
  • Becton Dickinson 2021 EBITDA was 4.481B, a 48.03% increase from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company NameMarket
Cap
McKesson (MCK)$78.2B
Cardinal Health (CAH)$28.6B
West Pharmaceutical Services (WST)$22B
Labcorp (LH)$19.8B
Cooper (COO)$19.7B
Align Technology (ALGN)$16.6B
Henry Schein (HSIC)$9.3B
Merit Medical Systems (MMSI)$6.1B
DENTSPLY SIRONA (XRAY)$3.8B
CONMED (CNMD)$2.2B
Patterson (PDCO)$1.8B
STAAR Surgical (STAA)$1.3B
Lifevantage (LFVN)$170M
Pro-Dex (PDEX)$147M